[Spanish adaptation of the 2016 European Guidelines on cardiovascular disease prevention in clinical practice].

[1]  D. Fernández,et al.  Clinical consequences of using the new cardiovascular risk tables SCORE OP in patients aged over 65 years , 2016 .

[2]  C. Brotons,et al.  Consecuencias clínicas de la utilización de las nuevas tablas de riesgo cardiovascular SCORE OP para pacientes mayores de 65 años , 2016 .

[3]  V. Ortún,et al.  Tax on Sugar Sweetened Beverages in Spain , 2016, Revista espanola de salud publica.

[4]  M. Royo-Bordonada,et al.  The extent and nature of food advertising to children on Spanish television in 2012 using an international food-based coding system and the UK nutrient profiling model. , 2016, Public health.

[5]  S. Yusuf,et al.  Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies , 2016, The Lancet.

[6]  D. De Bacquer,et al.  Cardiovascular risk estimation in older persons: SCORE O.P. , 2016, European journal of preventive cardiology.

[7]  Lenore J Launer,et al.  Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial. , 2016, JAMA.

[8]  J. Buse,et al.  Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. , 2016, The New England journal of medicine.

[9]  F. Rodríguez‐Artalejo,et al.  Vending Machines of Food and Beverages and Nutritional Profile of their Products at Schools in Madrid, Spain, 2014-2015. , 2016, Revista espanola de salud publica.

[10]  Jackson T. Wright,et al.  A Randomized Trial of Intensive versus Standard Blood-Pressure Control. , 2016, The New England journal of medicine.

[11]  M. Royo-Bordonada,et al.  Nutrition and health claims in products directed at children via television in Spain in 2012. , 2016, Gaceta sanitaria.

[12]  F. Kronenberg,et al.  Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Med , 2016, Clinical chemistry.

[13]  S. Yusuf,et al.  Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease. , 2016, The New England journal of medicine.

[14]  S. Yusuf,et al.  Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease. , 2016, The New England journal of medicine.

[15]  Stefan Störk,et al.  EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries , 2016, European journal of preventive cardiology.

[16]  S. Anderson,et al.  Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis , 2016, The Lancet.

[17]  D. Mozaffarian.  Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: A Comprehensive Review , 2016, Circulation.

[18]  M Arantxa Colchero,et al.  Beverage purchases from stores in Mexico under the excise tax on sugar sweetened beverages: observational study , 2016, British Medical Journal.

[19]  B. Zinman,et al.  Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. , 2015, The New England journal of medicine.

[20]  Improve-It Investigators.  Ezetimibe added to statin therapy after acute coronary syndromes , 2015 .

[21]  Ross A. Hammond,et al.  Smart food policies for obesity prevention , 2015, The Lancet.

[22]  A. Auchincloss,et al.  Impact of policy and built environment changes on obesity‐related outcomes: a systematic review of naturally occurring experiments , 2015, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[23]  A. Abernethy,et al.  Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial. , 2015, JAMA internal medicine.

[24]  D. Calhoun,et al.  Obstructive sleep apnea, hypertension and cardiovascular diseases , 2015, Journal of Human Hypertension.

[25]  C. Brotons,et al.  La ecuación ERICE: la nueva ecuación autóctona de riesgo cardiovascular para una población mediterránea envejecida y de bajo riesgo en España , 2015 .

[26]  M. Royo-Bordonada,et al.  Information search behaviour, understanding and use of nutrition labeling by residents of Madrid, Spain. , 2015, Public health.

[27]  J. Tuomilehto,et al.  The ERICE-score: the new native cardiovascular score for the low-risk and aged Mediterranean population of Spain. , 2015, Revista espanola de cardiologia.

[28]  K. Rahimi,et al.  Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis. , 2015, JAMA.

[29]  David E Newby,et al.  Expert position paper on air pollution and cardiovascular disease. , 2015, European heart journal.

[30]  D. Matthews,et al.  Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes , 2014, Diabetes Care.

[31]  R. Taylor,et al.  Cardiac rehabilitation for people with heart disease: an overview of Cochrane systematic reviews. , 2014, The Cochrane database of systematic reviews.

[32]  D. van der A,et al.  The validation of cardiovascular risk scores for patients with type 2 diabetes mellitus , 2014, Heart.

[33]  M. Woodward,et al.  Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data , 2014, The Lancet.

[34]  S. Blair,et al.  Leisure-time running reduces all-cause and cardiovascular mortality risk. , 2014, Journal of the American College of Cardiology.

[35]  A. Witzki,et al.  Results of a workplace health campaign: what can be achieved? , 2014, Deutsches Arzteblatt international.

[36]  F. Hu,et al.  Added sugar intake and cardiovascular diseases mortality among US adults. , 2014, JAMA internal medicine.

[37]  Isaac Subirana,et al.  Derivation and validation of a set of 10-year cardiovascular risk predictive functions in Spain: the FRESCO Study. , 2014, Preventive medicine.

[38]  B. Whalley,et al.  Psychological Interventions for Coronary Heart Disease: Cochrane Systematic Review and Meta-analysis , 2014, International Journal of Behavioral Medicine.

[39]  A. Husseini,et al.  A Cost Effectiveness Analysis of Salt Reduction Policies to Reduce Coronary Heart Disease in Four Eastern Mediterranean Countries , 2014, PloS one.

[40]  C. Brotons,et al.  El estado de la prevención cardiovascular en España , 2014 .

[41]  A. Perkins,et al.  Effect of Collaborative Care for Depression on Risk of Cardiovascular Events: Data From the IMPACT Randomized Controlled Trial , 2014, Psychosomatic medicine.

[42]  K. Bennett,et al.  Explaining the decline in coronary heart disease mortality in Turkey between 1995 and 2008 , 2013, BMC Public Health.

[43]  Hayden McRobbie,et al.  Electronic cigarettes for smoking cessation: a randomised controlled trial , 2013, The Lancet.

[44]  I. Perry,et al.  The effectiveness of workplace dietary modification interventions: a systematic review. , 2013, Preventive medicine.

[45]  T. Marwick,et al.  Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: a systematic review and meta-analysis. , 2013, European journal of cancer.

[46]  C. Vlachopoulos,et al.  Erectile dysfunction in the cardiovascular patient. , 2013, European heart journal.

[47]  Z. Kabir,et al.  Modelling the impact of specific food policy options on coronary heart disease and stroke deaths in Ireland , 2013, BMJ Open.

[48]  R. Peters,et al.  Effect of a nurse-coordinated prevention programme on cardiovascular risk after an acute coronary syndrome: main results of the RESPONSE randomised trial , 2013, Heart.

[49]  R. Perera,et al.  Pharmacological interventions for smoking cessation: an overview and network meta-analysis. , 2013, The Cochrane database of systematic reviews.

[50]  P. Mills,et al.  A Meta-Analysis of Mental Health Treatments and Cardiac Rehabilitation for Improving Clinical Outcomes and Depression Among Patients With Coronary Heart Disease , 2013, Psychosomatic medicine.

[51]  J. Ioannidis,et al.  Bias in associations of emerging biomarkers with cardiovascular disease. , 2013, JAMA internal medicine.

[52]  S. Sans,et al.  [Statement of the Spanish Interdisciplinary Cardiovascular Prevention Committee (CEIPC for its Spanish acronym) on the 2012 European Cardiovascular Prevention Guidelines]. , 2013, Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis.

[53]  S. Sans,et al.  [Statement of the Spanish Interdisciplinary Cardiovascular Prevention Committee (CEIPC) on the 2012 European Cardiovascular Prevention Guidelines]. , 2013, Revista espanola de salud publica.

[54]  F. Chaloupka,et al.  Assessing the potential effectiveness of food and beverage taxes and subsidies for improving public health: a systematic review of prices, demand and body weight outcomes , 2013, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[55]  R. Elosua,et al.  Impact of a Partial Smoke-Free Legislation on Myocardial Infarction Incidence, Mortality and Case-Fatality in a Population-Based Registry: The REGICOR Study , 2013, PloS one.

[56]  O. Franco,et al.  Population-level changes to promote cardiovascular health , 2012, European journal of preventive cardiology.

[57]  R. T. Lie,et al.  Cardiovascular mortality after pre-eclampsia in one child mothers: prospective, population based cohort study , 2012, BMJ : British Medical Journal.

[58]  J. Arenillas,et al.  Guidelines for the preventive treatment of ischaemic stroke and TIA (I). Update on risk factors and life style , 2012 .

[59]  P. Irimia,et al.  Guidelines for the preventive treatment of ischaemic stroke and TIA (I). Update on risk factors and life style. , 2012, Neurologia.

[60]  M. Buxton,et al.  Cost-effectiveness of a European preventive cardiology programme in primary care: a Markov modelling approach , 2012, BMJ Open.

[61]  F. Rodríguez‐Artalejo,et al.  Achievement of Cardiometabolic Goals in Aware Hypertensive Patients in Spain: A Nationwide Population-Based Study , 2012, Hypertension.

[62]  D. Mozaffarian,et al.  Population Approaches to Improve Diet, Physical Activity, and Smoking Habits: A Scientific Statement From the American Heart Association , 2012, Circulation.

[63]  Giel Nijpels,et al.  Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. , 2012, JAMA.

[64]  R. Collins,et al.  The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials , 2012, The Lancet.

[65]  T. Vos,et al.  Which Interventions Offer Best Value for Money in Primary Prevention of Cardiovascular Disease? , 2012, PloS one.

[66]  Ian Graham,et al.  EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE , 2005 .

[67]  Shah Ebrahim,et al.  European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.

[68]  Lu Gao,et al.  Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data , 2012, The Lancet.

[69]  F. Rodríguez‐Artalejo,et al.  Magnitude and Management of Hypercholesterolemia in the Adult Population of Spain, 2008-2010, The ENRICA Study , 2012 .

[70]  J. R. Banegas,et al.  Magnitude and management of hypercholesterolemia in the adult population of Spain, 2008-2010: The ENRICA Study. , 2012, Revista espanola de cardiologia.

[71]  Walter C Willett,et al.  Sweetened Beverage Consumption, Incident Coronary Heart Disease, and Biomarkers of Risk in Men , 2012, Circulation.

[72]  Peggy J. Liu,et al.  The science on front-of-package food labels , 2012, Public Health Nutrition.

[73]  M. Grau,et al.  Análisis de la disminución de la mortalidad por enfermedad coronaria en una población mediterránea: España 1988-2005 , 2011 .

[74]  Martin O'Flaherty,et al.  Analyzing the Coronary Heart Disease Mortality Decline in a Mediterranean Population: Spain 1988-2005 , 2011 .

[75]  M. Hill,et al.  Community Outreach and Cardiovascular Health (COACH) Trial: A Randomized, Controlled Trial of Nurse Practitioner/Community Health Worker Cardiovascular Disease Risk Reduction in Urban Community Health Centers , 2011, Circulation. Cardiovascular quality and outcomes.

[76]  Tim Marsh,et al.  Changing the future of obesity: science, policy, and action , 2011, The Lancet.

[77]  I-Min Lee,et al.  Dose Response Between Physical Activity and Risk of Coronary Heart Disease: A Meta-Analysis , 2011, Circulation.

[78]  M. Grau,et al.  Validez relativa de la estimación del riesgo cardiovascular a 10 años en una cohorte poblacional del estudio REGICOR , 2011 .

[79]  D. Fernández-Bergés,et al.  [Cardiovascular risk factors in Spain in the first decade of the 21st Century, a pooled analysis with individual data from 11 population-based studies: the DARIOS study]. , 2011, Revista espanola de cardiologia.

[80]  A. León,et al.  Cardiovascular Risk Factors in Spain in the First Decade of the 21st Century, a Pooled Analysis With Individual Data From 11 Population-Based Studies: the DARIOS Study , 2011 .

[81]  W. Ghali,et al.  Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies , 2011, BMJ : British Medical Journal.

[82]  Yikyung Park,et al.  Body-mass index and mortality among 1.46 million white adults. , 2010, The New England journal of medicine.

[83]  Florence Dumas,et al.  Sports-Related Sudden Death in the General Population , 2010, Circulation.

[84]  J. I. Cuende,et al.  How to calculate vascular age with the SCORE project scales: a new method of cardiovascular risk evaluation. , 2010, European heart journal.

[85]  L. Moran,et al.  Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. , 2010, Human reproduction update.

[86]  A. Bauman,et al.  The Toronto Charter for Physical Activity: a global call for action. , 2010, Journal of physical activity & health.

[87]  Sowmya R. Rao,et al.  Alcohol consumption and cardiovascular mortality among U.S. adults, 1987 to 2002. , 2010, Journal of the American College of Cardiology.

[88]  D. Symmons,et al.  EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis , 2009, Annals of the rheumatic diseases.

[89]  P. Juan.  Trans fatty acids (tFA): sources and intake levels, biological effects and content in commercial Spanish food. , 2009 .

[90]  F. Harrell,et al.  Criteria for Evaluation of Novel Markers of Cardiovascular Risk: A Scientific Statement From the American Heart Association , 2009, Circulation.

[91]  F. Álvarez,et al.  Guía europea de prevención cardiovascular en la práctica clínica: Adaptación española del CEIPC 2008 , 2008 .

[92]  A Hofman,et al.  Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. , 2008, JAMA.

[93]  P. Vokonas,et al.  Age-Dependent Associations Between Chronic Periodontitis/Edentulism and Risk of Coronary Heart Disease , 2008, Circulation.

[94]  M. Pencina,et al.  General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.

[95]  O. Pedersen,et al.  Effect of a multifactorial intervention on mortality in type 2 diabetes. , 2008, The New England journal of medicine.

[96]  K. Kalantar-Zadeh,et al.  Effect of Obesity on Short‐ and Long‐term Mortality Postcoronary Revascularization: A Meta‐analysis , 2008, Obesity.

[97]  R Peto,et al.  Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. , 2008, Lancet.

[98]  E. Schiffrin,et al.  Chronic Kidney Disease: Effects on the Cardiovascular System , 2007, Circulation.

[99]  Vera Bittner,et al.  Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Pr , 2007, Circulation.

[100]  I. Graham,et al.  Calibración de la tabla SCORE de riesgo cardiovascular para España , 2007 .

[101]  Ralph B D'Agostino,et al.  EVIDENCE BASED PUBLIC HEALTH POLICY AND PRACTICE Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA study , 2006 .

[102]  D. Mozaffarian,et al.  Trans fatty acids and cardiovascular disease. , 2006, The New England journal of medicine.

[103]  Bo Christensen,et al.  Motivational interviewing: a systematic review and meta-analysis. , 2005, The British journal of general practice : the journal of the Royal College of General Practitioners.

[104]  E. Vartiainen,et al.  Predicted and observed cardiovascular disease in South Asians: application of FINRISK, Framingham and SCORE models to Newcastle Heart Project data. , 2005, Journal of public health.

[105]  Fernando,et al.  Guía Europea de Prevención Cardiovascular en la Práctica Clínica. Adaptación Española del Comité Español Interdisciplinario para la Prevención Cardiovascular (CEIPC) 2008 , 2005 .

[106]  R. Hubbard,et al.  Risk of myocardial infarction and stroke after acute infection or vaccination. , 2004, The New England journal of medicine.

[107]  C. Brotons,et al.  Adaptación española de la Guía Europea de Prevención Cardiovascular. , 2004 .

[108]  Paige E. Scalf,et al.  Cardiovascular fitness, cortical plasticity, and aging. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[109]  Shah Ebrahim,et al.  European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. , 2003 .

[110]  S. Silber.  Comparison of spiral and electron beam tomography in the evaluation of coronary calcification in asymptomatic persons. , 2002, International journal of cardiology.

[111]  P. Whelton,et al.  Passive smoking and the risk of coronary heart disease--a meta-analysis of epidemiologic studies. , 1999, The New England journal of medicine.

[112]  M. Dennis.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee , 1996 .

[113]  G Rose,et al.  Sick individuals and sick populations. , 1985, International journal of epidemiology.

[114]  J. Danesh,et al.  Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. , 2011, Lancet.

[115]  P. Plans-Rubió.  The Cost Effectiveness of Statin Therapies in Spain in 2010, after the Introduction of Generics and Reference Prices , 2010, American journal of cardiovascular drugs : drugs, devices, and other interventions.

[116]  D. Clement.  A randomised, blinded, trial of Clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996 .